Article

UK-based BenevolentAI raised one of the largest fundings in AI pharmaceutical field. The company is significantly disrupting the pharma industry which spends $180 billion in a year on R&D.

You have read of your 8 free articles this month.

Subscribe to
Medgenera All-Access

Enjoy unlimited access to all contents, resources, exclusive market research reports, databases, surveys and many more features by subscribing to Medgenera All-Access.

Access articles & resources worth up to US $4, 000 per month.

Register with your email to read the full article.

This article is FREE for you! Unlock the unlimited access by subscribing to Medgenera All-Access.

More in ARTIFICIAL INTELLIGENCE


ARTIFICIAL INTELLIGENCE

AI-Based Pharma Startup BenevolentAI worth $2 Billion Raises $115 M Funding

UK-based BenevolentAI raised one of the largest fundings in AI pharmaceutical field. The company is significantly disrupting the pharma industry which spends $180 billion in a year on R&D.

Most Popular


GROW

7 New Ideas to Start a Healthcare Business in India (2018)

Highlights Herein, we are proposing the seven new healthcare business ideas in India in 2018 which are based on our ...

NEWLY PUBLISHED

Pharma Patents: Can India Reward Incremental Innovation?

Chandramouli Natarajan is an Associate Scientist, Ricon pharma LLC, Denville, USA. He has presented his opinion and views on the Pharmaceutical patents issues in India. This article is available for free to read and share.

Leave a reply